Ketogenic diets as an adjuvant therapy in glioblastoma (the KEATING trial): study protocol for a randomised pilot study

BACKGROUND: Glioblastoma is the commonest form of malignant brain tumour in adults, affecting 2–3 people per 100,000 per year. Despite current treatment options including surgical resection, radiotherapy and temozolomide chemotherapy, overall survival at 2 years is approximately 27%, with a median s...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Pilot Feasibility Stud
Main Authors: Martin-McGill, Kirsty J., Marson, Anthony G., Tudur Smith, Catrin, Jenkinson, Michael D.
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2017
Assuntos:
Study Protocol
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5704454/
https://ncbi.nlm.nih.gov/pubmed/29209515
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40814-017-0209-9
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares